Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 595)
Posted On: 01/07/2021 3:10:27 PM
Post# of 153911
Posted By: ohm20
Re: MD VIROLOGIST #71735
Quote:
Someone asked LL vs. Mav binding affinity to the receptor, Mav binds more avidly and can even displace LL. From BP.



Quote:
Occupancy of CCR5 receptors by maraviroc was studied in HIV-1–infected patients and was found to be >80% just before readministration at a steady state. Five days after discontinuation of the drug, the receptors remained >60% occupied



[https://academic.oup.com/cid/article/47/2/236/358070]https://academic.oup.com/cid/article/47/2/236/358070[/url]

With superior occupancy one would think it would have superior efficacy to leronlimab.

Quote:
At week 48, 67.3% maraviroc (=ART) recipients and 76.3% placebo (+ART) recipients achieved an undetectable viral load (VL <50 copies/mL; P=0.048).



https://www.jwatch.org/na50863/2020/02/21/can...vanced-hiv













(5)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site